Cargando…

Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency–Centromeric Instability–Facial Anomalies Syndrome Type 1

Detalles Bibliográficos
Autores principales: Kraft, Monica T., Mehyar, Lubna S., Prince, Benjamin T., Reshmi, Shalini C., Abraham, Roshini S., Abu-Arja, Rolla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862860/
https://www.ncbi.nlm.nih.gov/pubmed/33544358
http://dx.doi.org/10.1007/s10875-021-00984-x
_version_ 1783647382749052928
author Kraft, Monica T.
Mehyar, Lubna S.
Prince, Benjamin T.
Reshmi, Shalini C.
Abraham, Roshini S.
Abu-Arja, Rolla
author_facet Kraft, Monica T.
Mehyar, Lubna S.
Prince, Benjamin T.
Reshmi, Shalini C.
Abraham, Roshini S.
Abu-Arja, Rolla
author_sort Kraft, Monica T.
collection PubMed
description
format Online
Article
Text
id pubmed-7862860
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-78628602021-02-05 Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency–Centromeric Instability–Facial Anomalies Syndrome Type 1 Kraft, Monica T. Mehyar, Lubna S. Prince, Benjamin T. Reshmi, Shalini C. Abraham, Roshini S. Abu-Arja, Rolla J Clin Immunol Letter to Editor Springer US 2021-02-05 2021 /pmc/articles/PMC7862860/ /pubmed/33544358 http://dx.doi.org/10.1007/s10875-021-00984-x Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to Editor
Kraft, Monica T.
Mehyar, Lubna S.
Prince, Benjamin T.
Reshmi, Shalini C.
Abraham, Roshini S.
Abu-Arja, Rolla
Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency–Centromeric Instability–Facial Anomalies Syndrome Type 1
title Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency–Centromeric Instability–Facial Anomalies Syndrome Type 1
title_full Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency–Centromeric Instability–Facial Anomalies Syndrome Type 1
title_fullStr Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency–Centromeric Instability–Facial Anomalies Syndrome Type 1
title_full_unstemmed Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency–Centromeric Instability–Facial Anomalies Syndrome Type 1
title_short Immune Reconstitution after Hematopoietic Stem Cell Transplantation in Immunodeficiency–Centromeric Instability–Facial Anomalies Syndrome Type 1
title_sort immune reconstitution after hematopoietic stem cell transplantation in immunodeficiency–centromeric instability–facial anomalies syndrome type 1
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862860/
https://www.ncbi.nlm.nih.gov/pubmed/33544358
http://dx.doi.org/10.1007/s10875-021-00984-x
work_keys_str_mv AT kraftmonicat immunereconstitutionafterhematopoieticstemcelltransplantationinimmunodeficiencycentromericinstabilityfacialanomaliessyndrometype1
AT mehyarlubnas immunereconstitutionafterhematopoieticstemcelltransplantationinimmunodeficiencycentromericinstabilityfacialanomaliessyndrometype1
AT princebenjamint immunereconstitutionafterhematopoieticstemcelltransplantationinimmunodeficiencycentromericinstabilityfacialanomaliessyndrometype1
AT reshmishalinic immunereconstitutionafterhematopoieticstemcelltransplantationinimmunodeficiencycentromericinstabilityfacialanomaliessyndrometype1
AT abrahamroshinis immunereconstitutionafterhematopoieticstemcelltransplantationinimmunodeficiencycentromericinstabilityfacialanomaliessyndrometype1
AT abuarjarolla immunereconstitutionafterhematopoieticstemcelltransplantationinimmunodeficiencycentromericinstabilityfacialanomaliessyndrometype1